Jack Y. Zhang - 16 May 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Signature
/s/ Eva Wen, by power of attorney for Jack Y. Zhang
Issuer symbol
AMPH
Transactions as of
16 May 2022
Transactions value $
-$4,234,897
Form type
4
Filing time
18 May 2022, 16:06:27 UTC
Previous filing
18 Mar 2022
Next filing
20 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Sale -$1.93M -54.3K -2.32% $35.58 2.29M 16 May 2022 Direct F1, F2
transaction AMPH Common Stock Sale -$502K -13.8K -0.6% $36.41 2.27M 16 May 2022 Direct F1, F3
transaction AMPH Common Stock Sale -$1.7M -47.5K -2.09% $35.74 2.23M 17 May 2022 Direct F1, F4
transaction AMPH Common Stock Sale -$103K -2.84K -0.13% $36.14 2.22M 17 May 2022 Direct F1, F5
holding AMPH Common Stock 1.5M 16 May 2022 See footnote F6
holding AMPH Common Stock 6.83M 16 May 2022 See footnote F7
holding AMPH Common Stock 5K 16 May 2022 See footnote F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.195, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.63, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.065 to $36.06, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.07 to $36.27, inclusive.
F6 The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
F7 The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust are the sole owners.
F8 The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.